posted on 2023-06-30, 09:01authored byPatrick M. Meyer Sauteur, Mike BeetonMike Beeton, ESGMAC MAPS study group
Mycoplasma pneumoniae was a common cause of respiratory tract infections before the COVID-19 pandemic, with worldwide incidence of 8·61% from 2017 to 2020, measured by direct test methods.
However, non-pharmaceutical interventions (NPIs) against COVID-19 drastically lowered the transmission of M pneumoniae. In the short term, the incidence was down to 1·69% between 2020 and 2021. Lower transmission was also observed for other pathogens at the time. However, M pneumoniae transmission also showed long-term reductions during periods with relaxed or discontinued NPIs, with an incidence of 0·70% between 2021 and 2022.
During the same period infections with other pathogens resurged, indicating increased community transmission.
Meyer Sauteur, Patrick M. & Beeton, Michael L. on behalf of the ESGMAC MAPS study group (2023) 'Mycoplasma pneumoniae: gone forever? ,' The Lancet Microbe. doi : 10.1016/S2666-5247(23)00182-9